Fig. 3From: MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathwayHOXA9 was a direct target of miR-638 in breast cancer. (A) HOXA9 had binding sites with miR-638. (B) Luciferase reporter assay. (C) miR-638 had negative correlation with HOXA9. (D, E) The expression of HOXA9 were observed in MCF-7 cells containing miR-638 mimics or inhibitor **P <0.01Back to article page